Join to View Full Profile
28 Manitoba RdNewton, MA 02468
Dr. Moskowitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Pediatric Pulmonology, 1997 - 2001- University of WashingtonResidency, Pediatrics, 1994 - 1997
Harvard Medical SchoolClass of 1994
Certifications & Licensure
MA State Medical License 2008 - 2027
NH State Medical License 2023 - 2025
AK State Medical License 2006 - 2010
American Board of Pediatrics Pediatric Pulmonology
Clinical Trials
- Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF) Start of enrollment: 2004 Mar 01
Publications & Presentations
PubMed
- 22 citationsNon-respiratory health-related quality of life in people with cystic fibrosis receiving elexacaftor/tezacaftor/ivacaftor.Isabelle Fajac, Cori Daines, Isabelle Durieu, Jennifer L Goralski, Harry Heijerman
Journal of Cystic Fibrosis. 2023-01-01 - 51 citationsEfficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous forand a Minimal Function Mutation: A P...Marcus A Mall, Rossa Brugha, Silvia Gartner, Julian Legg, Alexander Moeller
American Journal of Respiratory and Critical Care Medicine. 2022-12-01 - 63 citationsEfficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-wee...Sivagurunathan Sutharsan, Edward F McKone, Damian G Downey, Jamie Duckers, Gordon MacGregor
The Lancet. Respiratory Medicine. 2022-03-01
Press Mentions
Characterization of Pseudomonas Aeruginosa from Subjects with Diffuse PanbronchiolitisOctober 8th, 2024
Grant Support
- Polymyxin-Resistant Pseudomonas In CF Lung InfectionNational Institute Of Allergy And Infectious Diseases2009–2010
- Polymyxin-Resistant Pseudomonas In CF Lung InfectionNational Institute Of Allergy And Infectious Diseases2007–2008
- Standard Versus Biofilm Susceptibility Testing In Cystic Fibrosis (CF)National Center For Research Resources2006
- Influence Of ENAC Regulators On CF Lung SeverityNational Heart, Lung, And Blood Institute2005–2006
- Genetics Of Cystic Fibrosis Lung SparingNational Center For Research Resources2004–2005
- Host-Pathogen Interactions In Cystic FibrosisNational Heart, Lung, And Blood Institute2001–2005
- Genetics Of Cystic Fibrosis Lung DiseaseNational Center For Research Resources2004
Industry Relationships
- Executive Medical Director, Vertex Pharmaceuticals2015 - 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
